期刊文献+

妊娠期糖尿病患者血清中胰高血糖素样肽-1及二肽基肽酶-IV的浓度检测及临床意义 被引量:3

The level and clinical significance of glucagon like peptide-1 and dipeptidyl peptidase-IV in gestational diabetes mellitus
原文传递
导出
摘要 目的:研究妊娠期糖尿病(GDM)患者血清中胰高血糖素样肽-1(GLP-1)和二肽基肽酶-IV(DPP-IV)的水平,并探讨其在妊娠期糖尿病中的作用。方法:采用ELISA法检测43例GDM患者、38例糖耐量正常孕妇及35例正常非孕妇血清GLP-1及DPP-IV的水平;同时测定3组妇女空腹血糖(FPG)、胰岛素(FINS)及糖化血红蛋白(HbA1c)的水平,并根据HOMA稳态模型提出的公式,计算胰岛素抵抗指数(HOMA-IR)和胰岛素分泌指数(HOMA-HBCI)进一步评价胰岛β细胞的功能。结果:①GDM患者血清GLP-1水平明显低于糖耐量正常孕妇组及正常非孕妇组,差异有统计学意义(P<0.05),血清DPP-IV水平明显高于糖耐量正常孕妇组及正常非孕妇组,差异有统计学意义(P<0.05);②GDM患者与另两组相比,存在明显的胰岛素抵抗(HOMA-IR明显增大,P<0.05),而胰岛素分泌明显下降(HOMA-HBCI明显减小,P<0.05),差异均有统计学意义。结论:GDM患者血清GLP-1水平明显下降,而DPP-IV水平明显升高,可能在GDM的发病中发挥一定的作用。 Objective:To investigate the serum levels of glucagon like peptide-1(GLP-1) and dipeptidyl peptidase-IV(DPP-IV) in gestational diabetes mellitus(GDM),and discuss the role of them in GDM. Methods:The serum levels of GLP-1 and DPP-IV in 43 GDM,38 pregnant women with normal glucose tolerance and 35 normal non-pregnant women were determined by ELISA,and fasting plasma glucose(FPG),insulin,glycosylated hemoglobin A1c(HbA1c) were also measured simultaneously,moreover,according to the HOMA stable state model,the insulin resistance index(HOMA-IR) and insulin secretion index(HOMA-HBCI) were calculated to further appraise the function of beta cell. Results:① Significantly reduced serum GLP-1 concentration and elevated serum DPP-IV concentration were found in the women with GDM as compared with normal glucose tolerance group and normal non-pregnant women group(P0.05).② Compared with the other two groups,obviously insulin resistance and insulin secretion decrease were discovered in GDM women. Conclusion:The secretion defect of GLP-1 and hypersecretion of DPP-IV may play a great part in the pathogenesis of gestational diabetes mellitus.
出处 《中国妇幼保健》 CAS 北大核心 2011年第8期1219-1221,共3页 Maternal and Child Health Care of China
关键词 妊娠期糖尿病 酶联免疫吸附测定 胰高血糖素样肽-1 二肽基肽酶-IV Gestational diabetes mellitus Enzyme-linked immunosorbent assay Glucagon like peptide-1 Dipeptidyl peptidase-IV
  • 相关文献

参考文献8

  • 1CyPryk K, Vilsb~Jll T, Nadel Iet al. Normal secretion of the incretin hormones glucose - dependent insulinotropic polypeptide and glucagon - like peptide- 1 during gestational diabetes mellitus [J] . Gynecol En- docrinol, 2007, 23 (1): 58.
  • 2Han SJ, Kim H J, Choi SEet al. Incretin secretion and serum DPP - IV activity in Korean patients with type 2 diabetes [ J] . Diabetes Res Clin Pract, 2010, 89 (3): e49.
  • 3李桦,马玉燕.正常妊娠母体糖代谢的变化[J].中国实用妇科与产科杂志,2007,23(6):459-461. 被引量:6
  • 4Koizumi M, Doi R, Fujinoto K et al. Pancreatic epithelial cells can be converted into insulin - Producing cells by GLP - 1 in conjunction with virus mediates gene transfer of Pdx - 1 [ J] . Surgery, 2005, 138:125.
  • 5Forbes S, Moonan M, Robinson S et al. Impaired circulating glucagon - like peptide - 1 response to oral glucose in women with previous gesta- tional diabetes [ J] . Clin Endocrinol (Oxf), 2005, 62 (1) : 51.
  • 6Vilsboll T, Krarup T, Deacon CF et al. Reduced postprandial concen- trations of intact biologically active glucagon - like peptide 1 in type 2 di- abetic palients [J] . Diabetes, 2001, 50:609.
  • 7Xu G, Kaneto H, Laybutt DR et al. Downregulation of GLP - 1 and GIP receptor expression by hyperglycemia: possible contribution to im- paired ineretin effects in diabetes [J] . Diabetes, 2007, 56. 1551.
  • 8Carr RD, Larsen MO, Jelic K et al. Secretion and dipeptidyl peptidase -4 - mediated metabolism of incretin hormones after a mixed meal ex glucose ingestion in obese compared to lean, nondiabetic men [ J ) . J Clin Endocrinol Metab, 2010, 95, 872.

二级参考文献18

  • 1Butte NF,Hopkinson JM,Mehta N,et al.Adjustments in energy expenditure and substrate utilization during late pregnancy and lactation[J].Am J Clin Nutr,1999,69:299-307.
  • 2Diabetes Association.Gestational diabetes mellitus[J].Diabetes Care,2003,26(Suppl 1):S103-105.
  • 3Lesser KB,Carpenter MW.Metabolic changes associated withnormal pregnancy and pregnancy complicated by diabetes mellitus[J].Semin Perinatol,1994,18:399-406.
  • 4Catalano PM,Tyzbir ED,Roman NM.Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women[J].Am J Obstet Gynecol,1991,165:1667-1672.
  • 5Buchanan TZ,Metzer BE,Frienkel N,et al.Insulin sensitivity and β cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glueese tolerance or mild gestational diabetes[J].Am J Obstet Gynecol,1990,162:1008-1014.
  • 6Catalano PM,Huston L,Amini SB,et al.Longitudinal change in glucose metabolism during pregnancy in obese women with normal slucosc tolerance and gestational diabetes mellitus[J].Am J Obstet Gyneeol,1999,180:903-916.
  • 7Rizza RA,Mandariono LJ,Gerich JE,et al.Cortisol-induced insulin resistance in man:impaired suppression of shcose production and stimulation of glucose utilization due to a postreceptor defect of insulin action[J].Clin Endoerinol Metab,1982,54:131-138.
  • 8Beck P,Daughday WH.Human placental lactogen:studies of its acute metabolic effects and disposition in normal man[J].J Clin Invest,1967,46:103-110.
  • 9Brelje TC,Scharp DW,Lacy PE,et al.Effect of homologous placental lactogens,prolactins,and growth hormones on islet β cell division and insulin secretion in rat,mouse.and human islet:implication for placental lactogen regulation of islet function during pregnancy[J].Endocrinology,1993,132:879-887.
  • 10Nelson T,Schulman G,Grainger D,et al.Progesterone administration induced impaired of insulin suppression of hepatic glucose production[J].Fertil Steril,1994,62:491-496.

共引文献5

同被引文献40

  • 1Buchanan TA, CatalanoPM. The pathogenesis of GDM : implication tbr diabetes after pregnancy[ J]. Diabetes, 1995,3:584 - 601.
  • 2Vilsb~l! T, Krarup T, Deacon CF, et al. Reduced postprandial con- centrations of inta~:t biologially aetive glucagon-like peptide 1 in typ~' 2 diabetic patients[J]. Diabetes,2001,50(3) :609 -613.
  • 3Toil-Nielsen MB, Damhoh MB, Madsbad S, et al. Determinants of the impaired sectetion of glucagon-like peptide-1 in type 2diabetic pa- tients [ J ]. J Clin Endocrinol Metab ,2001,86 ( 8 ) :3717 - 3723.
  • 4Habener JF. The incretin notion and its relevance to diabetes [ J ~. Endocrinol Metab Clin North Am,1993,22(4) :775 -794.
  • 5Calanna S, Gulud iI, Hoist JJ, et al. Secretion of glucagon-like pep- tide-I in patients with type 2 diabeess mellitus-systematic review and meta-analysis of clinical studies [ J ]. Diabetologia, 2013,56 ( 5 ) : 965 - 972.
  • 6Laaskso M,Zilinskaite J, Hansen T, et al. Insulin sensitivity, insulin release and glueagon-like peptide-llevels in persons with impaired fasting glucose and/or impaired glucose toleranee in the EUGENE2 study [ J 1. Diabetologia ,2008,51 ( 3 ) : 502 - 511.
  • 7Shih DQ, Heimesaat M, Kuwajima S, et al. Profound defeacts inpan- ereatic 13-eell function in mice with combined heterozygous mutations in Pdx-1 ,Hnf-lu,and Hnf-313[ Jl. Proe Natl Aead sei USA,2002, 99(6) :3818 -3823.
  • 8Gray P, Domhorst A. Gestational diabetes. A window in the develop- ment of non-insulin-dependent diabetes mellitus [ J 1- S Afr Med J, 1997,87(2) :201 -205.
  • 9Nauck MA, Meier JJ. Glucagon-like peptide l and its derivation in the treatment of diabetes [ J 1. Regul Pept,2005,128 ( 2 ) : 135 - 148.
  • 10Bonde L, Vilsb~ll T, Nielsen T, et al. Reduced postprandial GLP-I responses in women with gestational diabetes mellitus [ J 1. Diabetes Obes Metab ,2013,15 ( 8 ) :713 - 720.

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部